Top Markets
Coin of the day
Joyzyme Group Limited Joyzyme Group Limited

Joyzyme Group Limited

8622
Kedudukan dalam Saham #32060
Huakang Biomedical Holdings Company Limited operates as an investment holding... Huakang Biomedical Holdings Company Limited operates as an investment holding firm, primarily dedicated to the research, development, manufacturing, marketing, and distribution of in-vitro diagnostic (IVD) reagents within the People's Republic of China. Its comprehensive product portfolio encompasses IVD reagents designed for assessing male and female fertility, detecting parasite antibodies, and identifying the Epstein-Barr virus. Additionally, the company provides auxiliary reproductive supplies and equipment, alongside a range of healthcare products and nutritional supplements marketed under its 'Nutronic' brand, which are sold through both digital and physical platforms. Products are distributed directly to hospitals and medical institutions, as well as through a network of third-party distributors. The company was founded in 1992 and maintains its headquarters in Wan Chai, Hong Kong.
Harga Saham
$0.02187539
Modal Pasaran
$11.28M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-54.99%
Negara
HK
Perdagangan Joyzyme Group Limited (8622)

Kategori

Pendapatan untuk Joyzyme Group Limited (8622)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Joyzyme Group Limited, pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Joyzyme Group Limited dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa